% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • enabeler enabeler Mar 15, 2013 2:14 PM Flag

    First trade of the day was 315,770. Why?

    I just got home and noticed that the first trade today was 315,770 and then no trades for over 6 minutes. Seems a little unusual. But with this stock nothing would totally surprise me. The NCCN lunch symposium on metastatic prostate cancer as a chronic disease paradigm is ending right about now, but I would be shocked if there were any leaks.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Options expiration. Same pattern every month.

    • $$$$

      I can't speak for the nature of the first daily trade, but I would expect little in the way of immediate response to any activities at the NCCN annual meeting. That response will be assimilative, accumulative, and so very gradual as to be imperceptible - unitl we get a compendium listing that suggests a pool of revenue potential beyond MTC. The clinical mojo seems to suggest that Cabo has a niche in many a refractory metastatic setting, and - given a changing treatment landscape - as those unmet needs become manifest, I would expect to see further interest in Cabo's unique anti-angiogenic attributes. I see multiple listings in the compendium as inevitable, given Cabo's undeniable targeted activity despite multiple lines of treatment-induced resistance. The NCCN designated category of utilization will be key to the imbursement process. I believe Ernie pointed out that many payors will cover 2b or anything less will be uneventful in terms of revenue and unlikely to have an impact on PPS.

5.47-0.02(-0.36%)Nov 27 1:00 PMEST